17 results
10-K
2023 FY
NMRA
Neumora Therapeutics, Inc. Common Stock
7 Mar 24
Annual report
4:05pm
or environmental safety of new chemical or biological substances. Non-clinical (pharmaco-toxicological) studies must be conducted in compliance with the principles … of the jurisdictions in which we operate, including, without limitation, employment, foreign corrupt practices, trade restrictions and sanctions, environmental
424B4
NMRA
Neumora Therapeutics, Inc. Common Stock
18 Sep 23
Prospectus supplement with pricing info
4:12pm
, without limitation, employment, foreign corrupt practices, trade restrictions and sanctions, environmental, competition, and patient privacy and other
S-1/A
NMRA
Neumora Therapeutics, Inc. Common Stock
11 Sep 23
IPO registration (amended)
6:07am
operate, including, without limitation, employment, foreign corrupt practices, trade restrictions and sanctions, environmental, competition, and patient
S-1/A
EX-1.1
eap nk9mwtwo7d7624j
11 Sep 23
IPO registration (amended)
6:07am
S-1
EX-2.1
1qcci5rv
25 Aug 23
IPO registration
5:03pm
S-1
b6zwp48p539bf0lbj
25 Aug 23
IPO registration
5:03pm
S-1
EX-2.2
6bwhtui5btlij
25 Aug 23
IPO registration
5:03pm
DRS/A
ca01vu 07od
9 Aug 23
Draft registration statement (amended)
12:00am
DRS/A
xkvw735v5ljoz
30 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
09yhrw g85fa25l4oawy
2 May 23
Draft registration statement (amended)
12:00am
DRS/A
uj4ch94pwbjh1m 6x8e
2 Sep 22
Draft registration statement (amended)
12:00am
DRS/A
for3 2s8l
10 Jun 22
Draft registration statement (amended)
12:00am
DRS/A
kj2z3t3mgrw9fbgwpgf
2 May 22
Draft registration statement (amended)
12:00am
DRS/A
audizn7p8afuzfjzl5t
23 Dec 21
Draft registration statement (amended)
12:00am
DRS
j57jl mcpl
8 Nov 21
Draft registration statement
12:00am
- Prev
- 1
- Next